Skip to main content
. 2019 May 23;2019(5):CD009613. doi: 10.1002/14651858.CD009613.pub4

1.32. Analysis.

1.32

Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 32 Relevant biomarker changes associated with the intervention (cord blood c‐peptide levels > 2725 pmol/L).